Your browser doesn't support javascript.
loading
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women.
Gupta, Nidhi; Gupta, Dharna; Dixit, Jyoti; Mehra, Nikita; Singh, Ashish; Krishnamurthy, Manjunath Nookala; Jyani, Gaurav; Rajsekhar, Kavitha; Kalaiyarasi, Jayachandran Perumal; Roy, Partha Sarathi; Malik, Prabhat Singh; Mathew, Anisha; Malhotra, Pankaj; Gupta, Sudeep; Kumar, Lalit; Kataki, Amal; Prinja, Shankar.
Affiliation
  • Gupta N; Department of Radiation Oncology, Government Medical College and Hospital, Chandigarh, India.
  • Gupta D; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Dixit J; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Mehra N; Department of Medical Oncology, Adyar Cancer Institute, Chennai, Tamil Nadu, India.
  • Singh A; Department of Medical Oncology, Christian Medical College, Vellore, Tamil Nadu, India.
  • Krishnamurthy MN; Department of Clinical Pharmacology, Tata Memorial Centre, Mumbai, Maharashtra, India.
  • Jyani G; Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Rajsekhar K; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Kalaiyarasi JP; Department of Health Research, Ministry of Health and Family Welfare, New Delhi, India.
  • Roy PS; Department of Medical Oncology, Adyar Cancer Institute, Chennai, Tamil Nadu, India.
  • Malik PS; Department of Medical Oncology, Dr. B. Booroah Cancer Institute, Guwahati, Assam, India.
  • Mathew A; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Malhotra P; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Gupta S; Department of Internal Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Kumar L; Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.
  • Kataki A; Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Prinja S; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Appl Health Econ Health Policy ; 20(4): 609-621, 2022 07.
Article in En | MEDLINE | ID: mdl-35534752
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Main subject: Breast Neoplasms Type of study: Health_economic_evaluation / Prognostic_studies Limits: Female / Humans Language: En Journal: Appl Health Econ Health Policy Journal subject: SAUDE PUBLICA / SERVICOS DE SAUDE Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Main subject: Breast Neoplasms Type of study: Health_economic_evaluation / Prognostic_studies Limits: Female / Humans Language: En Journal: Appl Health Econ Health Policy Journal subject: SAUDE PUBLICA / SERVICOS DE SAUDE Year: 2022 Type: Article